
Shares of COVID vaccine makers plummet after US backs IP waiver
NY Post
Shares of Moderna and other makers of the COVID-19 vaccines plummeted after the US backed a plan to waive intellectual property protections for the life-saving products.
Moderna stock fell more than 6 percent Wednesday after the announcement and extended those losses a further 2 percent in premarket trading on Thursday. Pfizer shares were down more than 3 percent in that same period and shares of its vaccine partner BioNTech were down more than 7 percent. U.S. Trade Representative Katherine Tai announced Wednesday that the US will advocate for the “extraordinary measures,” which would potentially enable companies in developing countries to manufacture their own versions of the vaccines, increasing the supply globally.More Related News

Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
Brent crude oil held above $100 per barrel on Monday, pushing national average gasoline prices to their highest level since October 2023 as President Trump urged allies to help protect oil tankers from Iranian attacks in the key Strait of Hormuz.












